Brief: Carerx Posts Quarterly Loss Per Share Of $0.11
Nov 9 (Reuters) - CareRx Corp CRRX.TO :
* CARERX REPORTS 56% YEAR-OVER-YEAR GROWTH IN REVENUE AND
79%
YEAR-OVER-YEAR GROWTH IN ADJUSTED EBITDA FOR THE THIRD QUARTER
OF 2021
* QTRLY REVENUE FROM CONTINUING OPERATIONS INCREASED 56% TO
$71.3
MILLION
* QTRLY LOSS PER SHARE $0.11
* Q3 EARNINGS PER SHARE VIEW C$-0.11, REVENUE VIEW C$64.6
MILLION
-- REFINITIV IBES DATA
Source text for Eikon: ID:nCNWSC24ca
Further company coverage: CRRX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CareRx
See all newsCanada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates
Brief: CareRx Reports Results For The Third Quarter Of 2024